Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis
Robin P. Boushey(University of Ottawa), Daniel J. Drucker(Mount Sinai Hospital), Bernardo Yusta(Lunenfeld-Tanenbaum Research Institute)
American Journal of Physiology-Endocrinology and Metabolism
November 1, 1999
Cited by 178
Related Papers
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
|Clinics in Colon and Rectal Surgery|2009|2k
The role of gut hormones in glucose homeostasis
|Journal of Clinical Investigation|2007|611
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
|Endocrine Reviews|2014|602
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
|Diabetes Care|2003|578
Practice Parameters for the Management of Rectal Cancer (Revised)
|Diseases of the Colon & Rectum|2013|565